Inventor · disambiguated record
Jan Tebbe
Also filed as: TEBBE JAN · TEBBE JAN HERMAN LUCIEN
17 granted patents·15 pending applications·74 citations·filing 1995–2025
91Inventor score
Files withBAYER AG6BASF Agricultural Solutions Seed US LLC3BAYER HEALTHCARE LLC3BAYER IP GMBH3CRISPR THERAPEUTICS AG3
Top patents by PatentIndex Score
32 records- 0194US10973923B2Site specific homogeneous with KSP inhibitorsBayer Pharma AG·Filed 2016·Granted Apr 13, 2021·8 cites·37 claims
- 0286US10597674B2HPPD variants and methods of useBASF Agricultural Solutions Seed US LLC·Filed 2016·Granted Mar 24, 2020·5 cites·37 claims
- 0385US8399627B2Antibodies to TNFαVOTSMEIER CHRISTIAN·Filed 2008·Granted Mar 19, 2013·17 cites·12 claims
- 0484US8481030B2Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)WANG ZHUOZHI·Filed 2011·Granted Jul 9, 2013·12 cites·6 claims
- 0583US9657111B2Humanized monoclonal antibodies against activated protein C and uses thereofBAYER HEALTHCARE LLC·Filed 2013·Granted May 23, 2017·6 cites·19 claims
- 0681US11180770B2HPPD variants and methods of useBASF Agricultural Solutions Seed US LLC·Filed 2018·Granted Nov 23, 2021·3 cites·25 claims
- 0775US11578323B2RNA-programmable endonuclease systems and their use in genome editing and other applicationsCRISPR THERAPEUTICS AG·Filed 2018·Granted Feb 14, 2023·2 cites·5 claims
- 0873US9309324B2Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)WANG ZHUOZHI·Filed 2011·Granted Apr 12, 2016·3 cites·10 claims
- 0971US2025236654A1C-type natriuretic peptide engrafted antibodiesBAYER AG·Filed 2024·Application pending·0 cites
- 1068US9534046B2Antibodies to TNFαBAYER IP GMBH·Filed 2015·Granted Jan 3, 2017·1 cites·18 claims
- 1165US12203110B2RNA-programmable endonuclease systems and uses thereofCRISPR THERAPEUTICS AG·Filed 2019·Granted Jan 21, 2025·0 cites·10 claims
- 1264US11806404B2Site specific homogeneous with KSP inhibitorsBayer Pharma AG·Filed 2021·Granted Nov 7, 2023·0 cites·18 claims
- 1361US2024124572A1INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDINGBAYER AG·Filed 2022·Application pending·0 cites
- 1461US2025361282A1Atrial natriuretic peptide engrafted antibodiesBAYER AG·Filed 2025·Application pending·0 cites
- 1561US2024317847A1INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDINGBAYER AG·Filed 2022·Application pending·0 cites
- 1659US12331094B2Atrial natriuretic peptide engrafted antibodiesBAYER AG·Filed 2019·Granted Jun 17, 2025·0 cites·18 claims
- 1758US2025320477A1Novel rna-programmable endonuclease systems and uses thereofCRISPR THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 1857US2025188189A1Human antibodies against activated protein c and uses thereofCOAGULANT THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 1956US2021079056A1C-type natriuretic peptide engrafted antibodiesBAYER AG·Filed 2019·Application pending·0 cites
- 2055USRE49099EHumanized monoclonal antibodies against activated protein c and uses thereofBAYER HEALTHCARE LLC·Filed 2013·Granted Jun 7, 2022·0 cites·19 claims
- 2152US2008160558A1Process for generating sequence-specified proteases by directed evolution and use thereofDIREVO BIOTECH AG·Filed 2007·Application pending·0 cites
- 2252US2006269538A1Serine proteases with altered sensitivity to activity-modulating substancesKOLTERMANN ANDRE·Filed 2006·Application pending·0 cites
- 2351US2017158775A1Anti-c4.4a antibodies and uses thereofBAYER IP GMBH·Filed 2017·Application pending·0 cites
- 2449USRE47150EOptimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)BAYER HEALTHCARE LLC·Filed 2011·Granted Dec 4, 2018·0 cites·24 claims
- 2549US5753378ALaminated structural material and method for producing sameFiled 1995·Granted May 19, 1998·17 cites·20 claims
- 2648US2013230886A1Antibodies to TNF AlphaVOTSMEIER CHRISTIAN·Filed 2013·Application pending·0 cites
- 2747US12390508B2Brain natriuretic peptide engrafted antibodiesBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 19, 2025·0 cites·17 claims
- 2847US2014322220A1Anti-FGFR2 Antibodies and Uses ThereofBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 2945US2004072276A1Process for generating sequence-specific proteases by directed evolution and use thereofDIREVO BIOTECH AG·Filed 2003·Application pending·0 cites
- 3041US2012321619A1Anti-c4.4a antibodies and uses thereofLINDEN LARS·Filed 2010·Application pending·0 cites
- 3140US11371056B2HPPD variants and methods of useBASF Agricultural Solutions Seed US LLC·Filed 2018·Granted Jun 28, 2022·0 cites·24 claims
- 3232US2012237496A1Protease variantsBIRKENFELD JOERG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Tebbe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →